Interactions between β-herpesviruses and human immunodeficiency virus in vivo: Evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6

Journal of Medical Virology

Volumn 57, Issue 3, 1999, Pages 278-282

  Emery, Vincent C ^a   Atkins, Mark C ^a   Bowen, E Frances ^a   Clark, Duncan A ^a   Johnson, Margaret A ^a   Michael Kidd, I ^a   McLaughlin, James E ^a   Phillips, Andrew N ^a   Strappe, Padraig M ^a   Griffiths, Paul D ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cofactor; Postmortem; QCPCR

Indexed keywords

VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CADAVER; CONTROLLED STUDY; CORRELATION FUNCTION; DNA DETERMINATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; NONHUMAN; ORGAN DISTRIBUTION; PROVIRUS; RISK FACTOR; SUPERINFECTION; VIRUS DETECTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CYTOMEGALOVIRUS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HIV-1; HUMANS; VIRAL LOAD;

EID: 0032929937     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199903)57:3<278::AID-JMV11>3.0.CO;2-3     Document Type: Article

References (45)

1. Atkins MC, Carlin EM, Emery VC, Griffiths PD, Boag F. 1996. Fluctuations of HIV load in semen of HIV-positive patients with newly acquired sexually-transmitted diseases. Br Med J 313:341-342.
2. Bowen F, Wilson P, Cope A, Sabin C, Griffiths P, Davey C, Johnson J, Emery V. 1996. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 10:1515-1520.
3. Carrigan DR, Knox KK, Tapper MA. 1990. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J Inf Dis 162:844-851.
4. Clark DA, Ait-Khaled M, Wheeler AC, et al. 1996. Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J Gen Virol 77:2271-2275.
5. Corbellino M, Lusso P, Gallo RC, Parravicini C, Galli M, Moroni M. 1993. Disseminated human herpesvirus 6 infection in AIDS. Lancet 342:1242
6. Crowley RW, Secchiero P, Zella D, Cara A, Gallo RC, Lusso O. 1996. Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes. J Immunol 156:2004-2008.
7. Detels R, Leach CT, Hennessey K, Liu Z, Visscher BR, Cherry JD. 1994. Persistent cytomegalovirus infection of semen increases risk of AIDS. J Infect Dis 169:766-768.
8. Ensoli B, Lusso P, Schachter F, et al. 1989. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J 8:3019-3027.
9. Fox JC, Griffiths PD, Emery VC. 1992. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol 73:2405-2408.
10. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. 1992. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine: the Zidovudine Epidemiology Study Group. J Infect Dis 166:1223-1227.
11. Gendelman HE, Phelps W, Feigenbaum L, et al. 1986. Transactivation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci USA 83: 9759-9763.
12. Glesby MJ, Moore RD, Chaisson RE. 1995. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Inf Dis 21:370-375.
13. Compels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin ME, Efstathiou S, Craxton M, Macaulay HA. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51.
14. Griffiths PD. 1992. Studies to define viral cofactors for human immunodeficiency virus. Inf Agents Dis 1:237-244.
15. Griffiths PD. 1998. Studies to further define viral co-factors for human immunodeficiency virus. J Gen Virol 79:213-220.
16. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R. 1993. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis: multicenter AIDS Cohort Study. N Engl J Med 329: 1922-1926.
17. Katsafanas GC, Schirmer EC, Wyatt LS, Frenkel N. 1996. In vitro activation of human herpesvirus-6 and -7 from latency. Proc Natl Acad Sci USA 93:9788-9792.
18. Kidd IM, Clark DA, Ait-Khaled M, Griffiths PD, Emery VC. 1996. Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis 174:396-401.
19. Kidd IM, Clark DA, Bremner JAG, Pillay D, Griffiths PD, Emery VC. 1998. A multiplex PCR assay for the simultaneous detection of human herpesviruses 6 and 7, with typing of HHV-6 by enzyme cleavage of PCR products. J Virol Methods 70:29-36.
20. Knox KK, Carrigan DR. 1994. Disseminated active HHV-6 infections in patients with AIDS. Lancet 343:577-578.
21. Knox KK, Carrigan DR. 1996. Active HHV-6 infection in the lymph nodes of HTV-infected patients: in vitro evidence that HHV-6 can break HIV latency. J AIDS Human Retrovirol 11:370-378.
22. Koval V, Clark C, Vaishnav M, Spector SA, Spector DH. 1991. Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. J Virol 65:6969-6978.
23. Koval V, Jault FM, Pal PG, et al. 1995. Differential effects of human cytomegalovirus on integrated and unintegrated human immunodeficiency virus sequences. J Virol 69:1645-1651.
24. Levy JA, Landay A, Lennette ET. 1990. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Micro 28:2362-2364.
25. + T lymphocytes by HIV-1 and HHV-6. Nature 337: 370-373.
26. + T lymphocytes by human herpesvirus 6. Nature 349:533-535.
27. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC. 1993. Infection of natural killer cells by human herpesvirus 6. Nature 362:458-462.
28. Lusso P, Secchiero P, Crowley RW, et al. 1994. CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc Natl Acad Sci USA 91:3872-3876.
29. Lusso P, Gallo RC. 1995. Human herpesvirus 6. Baillieres Clin Haematol 8:201-223.
30. McKeating JA, Griffiths PD, Weiss RA. 1990. HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 343:659-661.
31. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
32. Moore RD, Chaisson RE. 1996. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Int Med 124: 633-642.
33. Nelson JA, Reynolds-Kohler C, Oldstone MB, Wiley CA. 1988. HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165:286-290.
34. Nicholas J. 1996. Determination and analysis of the complete nucleotide sequence of human herpesvirus. J Virol 70:5975-5989.
35. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. 1992. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J AIDS 5:1069-1074.
36. Pieskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M. 1997. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276:1874-1878.
37. Pillay D, Lipman MC, Lee CA, Johnson MA, Griffiths PD, McLaughlin JE. 1993. A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. AIDS 7:969-974.
38. Rabkin CS, Hatzakis A, Griffiths PD, et al. 1993. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus infected hemophilia patients: National Cancer Institute Multicentre Hemophilia Cohort Study Group. J Inf Dis 168:1260-1263.
39. Sabin CA, Phillips AN, Lee CA, Janossy G, Emery VC, Griffiths PD. 1995. The effect of CMV infection on progression of human immunodeficiency virus disease in a cohort of haemophilic men followed for up to 13 years from seroconversion. Epidemiol Inf 114:361-372.
40. Spector SA, Wong R, Hsia K, Pilcher M, Stemplen MJ. 1998. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest 101:497-502.
41. Thomson BJ, Efstathiou S, Honess RW. 1991. Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature 351:78-80.
42. Thomson BJ, Weindler FW, Gray D, Schwaab V, Heilbronn R. 1994. Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression. Virology 204:304-311.
43. Webster A, Lee CA, Cook DG, et al. 1989. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 2:63-66.
44. Webster A, McLaughlin JE, Johnson MA, Emery VC, Griffiths PD. 1995. Use of the Polymerase chain reaction to detect genomes of human immunodeficiency virus and cytomegalovirus in post-mortem tissues. J Med Virol 47:23-28.
45. Wyatt LS, Frenkel N. 1992. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 66:3206-3209.